DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging

Abstract

Antibody against stage specific embryonic antigen-1 is radiolabeled by direct means with a radionuclide for use in detection of occult abscess and inflammation. Radiolabeling is accomplished by partial reduction of the disulfide bonds of the antibody using Sn(II), or using other reducing agents followed by the addition of Sn(II), removal of excess reducing agent and reduction by-products, and addition of a specified amount of radionuclide reducing agent, such as stannous tartrate. The resulting product may be store frozen or lyophilized, with radiolabeling accomplished by the addition of the radionuclide.

Inventors:
 [1]
  1. Albuquerque, NM
Issue Date:
Research Org.:
RhoMed, Inc., Albuquerque, NM
OSTI Identifier:
869490
Patent Number(s):
5346687
Assignee:
Rhomed Incorporated (Albuquerque, NM)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
DOE Contract Number:  
FG04-89ER60899
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
direct; radiolabeling; antibody; stage; specific; embryonic; antigen; diagnostic; imaging; antigen-1; radiolabeled; means; radionuclide; detection; occult; abscess; inflammation; accomplished; partial; reduction; disulfide; bonds; ii; reducing; agents; followed; addition; removal; excess; agent; by-products; specified; amount; stannous; tartrate; resulting; product; store; frozen; lyophilized; reducing agents; resulting product; reducing agent; specific embryonic; stage specific; diagnostic imaging; occult abscess; embryonic antigen-1; embryonic antigen; agents followed; /424/530/

Citation Formats

Rhodes, Buck A. Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging. United States: N. p., 1994. Web.
Rhodes, Buck A. Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging. United States.
Rhodes, Buck A. Sat . "Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging". United States. https://www.osti.gov/servlets/purl/869490.
@article{osti_869490,
title = {Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging},
author = {Rhodes, Buck A},
abstractNote = {Antibody against stage specific embryonic antigen-1 is radiolabeled by direct means with a radionuclide for use in detection of occult abscess and inflammation. Radiolabeling is accomplished by partial reduction of the disulfide bonds of the antibody using Sn(II), or using other reducing agents followed by the addition of Sn(II), removal of excess reducing agent and reduction by-products, and addition of a specified amount of radionuclide reducing agent, such as stannous tartrate. The resulting product may be store frozen or lyophilized, with radiolabeling accomplished by the addition of the radionuclide.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Sat Jan 01 00:00:00 EST 1994},
month = {Sat Jan 01 00:00:00 EST 1994}
}

Works referenced in this record:

The labeling of high affinity sites of antibodies with 99mTc
journal, January 1985


Nonlymphoblastic Leukemia-Associated Antigens Identified by Monoclonal Antibodies
book, January 1985


Stage-specific embryonic antigen involves αl→ 3 fucosylated type 2 blood group chains
journal, July 1981


Covalent attachment of chelating groups to macromolecules
journal, July 1977


Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1).
journal, November 1978